February 5, 2024 knowmade

Your one-stop hub for all things mRNA

Discover the intricacies of mRNA and its rapidly advancing technologies with the assistance of KnowMade’s patent expertise.

  • Gain access to valuable insights on the latest mRNA patent news at no cost.
  • Delve deeper into the field with our comprehensive reports.
  • Stay at the forefront of research and development and intellectual property advancements through our monitoring services.

Insights

Featured image of the post Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting.
Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting
SOPHIA ANTIPOLIS, France – May 13, 2024 │ KnowMade actively follows therapeutic mRNA news for its Therapeutic mRNA patent monitor service! What’s new today? REPLICATE [...]
Featured image of our press release upon Q4 2023 patent monitor.
Q4 2023 Therapeutic mRNA patent monitor report: IP dynamic overview
SOPHIA ANTIPOLIS, France – January 22, 2024 │ The quarterly report for the Q4 2023 Therapeutic mRNA patent monitor is now available! This report covers [...]
Featured image of the article A look back at mRNA patenting activity for 2023.
A look back at mRNA patenting activity for 2023
SOPHIA ANTIPOLIS, France – January 16, 2024 │ The last quarterly report for the 2023 Therapeutic mRNA patent monitor is now available! This report covers [...]
mRNA Competitive landscape monitoring: A patent perspective – Poster
SOPHIA ANTIPOLIS, France – November 15, 2023 │ KnowMade’s Therapeutic mRNA Patent Monitor was presented at the 11th mRNA health conference in Berlin (October 31 [...]
ReNAgade Therapeutics unveiled new LNPs for delivering mRNA to extra-hepatic tissues: Patent analysis on its proprietary ionizable lipids
SOPHIA ANTIPOLIS, France – November 06, 2023 │ReNAgadeTherapeutics, a company founded in 2021 and based in Cambridge, presented preclinical data demonstrating a new and proprietary [...]
Q3 2023 Therapeutic mRNA patent monitor report: focus on mRNA modifications for an improved efficiency
SOPHIA ANTIPOLIS, France – October 25, 2023 │ The quarterly report for the Q3 2023 Therapeutic mRNA patent monitor is now available! This report covers [...]

Reports

Featured image of saRNA patent landscape report. mRNA cancer therapeutics patent landscape featured image. Featured image of RNA vaccine patent landscape.
Self-amplifying RNA vaccines Patent Landscape Analysis 2023 mRNA Cancer Therapies Patent Landscape Analysis 2022 RNA vaccine Patent Landscape 2021

Monitor

mRNA patent monitor featured image.
Therapeutic mRNA Patent Monitor